EXACT Sciences: Patience Required for Long-Term Upside [View article]
That's funny they compared their data with OncoMethylone (i had never even heard of it before), because that data is terrible. A decent blood based test will destroy exas, they will be obsoleted before they even start.
By precancer i assume you just mean polyps. Others using blood are aiming for much higher than that. The goal is maximizing the detection of cancer, finding the correct ratio to minimize false positives and false negatives. Others have much better performance than exas has shown. exas is not in the lead. I'm surprised you don't know this. exas will tell you who the other players are, just ask. Or ask your extensive network of advisors and pharmacists.
Regarding EXAS, all else equal, what do you think is better, a blood draw to detect colon cancer or a stool test? Lots of companies are working on the blood test. Blood you get a sample taken at the doctors office. Stool you take a kit home, poop into a small cup, scoop out the necessary amount and mail back to the lab. Commercially speaking, exas may be obsoleted before they even finish their trial.
EXACT Sciences: Patience Required for Long-Term Upside [View article]
Rodman Conference Recaps: EXACT Sciences, Delcath, Unilife [View article]
Rodman Conference Recaps: EXACT Sciences, Delcath, Unilife [View article]
Sequenom Splattered, Exact Sciences Could Benefit [View article]
Create Your Own Diagnostics ETF [View article]